Protests Move To Montgomery, Hoover Mayor Speaks Out
Hoover Mayor Frank Brocato says the city plans to defend the unidentified officer who shot and killed Emantic Bradford Jr. in any potential civil litigation.
This comes one day after Attorney General Steve Marshall‘s office released a report by the State Bureau of Investigation that cleared the officer of wrongdoing.
Source: Sherrel Wheeler Stewart,WBHM
Mayor Frank Brocato speaks to media.
In a press conference Wednesday morning, Brocato says he “respects the attorney general’s findings and encourages everyone to read the report in full.”
Bradford was killed Thanksgiving night at the Riverchase Galleria in Hoover. He was shot by a Hoover police officer responding to gunfire inside the mall. When the officer arrived on the scene, he says he saw Bradford with a gun and assumed he was a threat.
Bradford was running towards his friend, Brian Wilson when the officer fired three bullets from behind into Bradford’s head, neck and back. Wilson was wounded by Erron Brown, who fled the scene and said he was acting in self-defense when he shot Wilson.
Outraged by the report findings, activists moved their efforts Wednesday to the state capitol in Montgomery. Joining them were members of Bradford’s family, who say they plan to file a civil suit against the officer who shot Bradford, and against the city of Hoover.
Protesters for #EmanticBradfordJr are at the state capitol today in response to @AGSteveMarshall‘s recent report that cleared the officer who shot Bradford. They’re chanting “hands up, don’t shoot” while carrying signs.
Courtesy of @TroyPublicRadio‘s @kdgassiott. pic.twitter.com/ba9mhOc28T
— WBHM 90.3 FM (@WBHM) February 6, 2019
This is their latest attempt after two months of intermittent protesting throughout Hoover. Thev’ve marched outside the home of Mayor Frank Brocato, the mall where Bradford was killed, and blocked busy roads and interstates.
The protesters continue to ask that the entire video of the shooting be released ,along with the identity of the officer who shot him. But AG Steve Marshall told WBHM in an interview there is no reason to reveal his identity.
“If any other individual were investigated by law enforcement and there was no determination a crime was committed, that information wouldn’t be public,” Marshall said. “There’s no reason for an officer to be treated any differently.”
Marshall says there is no value to the public in knowing his identity. Meanwhile, Hoover Mayor Brocato says he does not know the officer directly, but that he will go “through a process” outlined by Hoover Police Chief Nick Derzis in order to return to work.
Watch Here: Video Of The Shooting Released By The Attorney General’s Office
What’s your favorite thing about Alabama?
That's the question we put to those at our recent News and Brews community pop-ups at Hop City and Saturn in Birmingham.
Q&A: A former New Orleans police chief says it’s time the U.S. changes its marijuana policy
Ronal Serpas is one of 32 law enforcement leaders who signed a letter sent to President Biden in support of moving marijuana to a Schedule III drug.
How food stamps could play a key role in fixing Jackson’s broken water system
JXN Water's affordability plan aims to raise much-needed revenue while offering discounts to customers in need, but it is currently tied up in court.
Alabama mine cited for federal safety violations since home explosion led to grandfather’s death, grandson’s injuries
Following a home explosion that killed one and critically injured another, residents want to know more about the mine under their community. So far, their questions have largely gone unanswered.
Crawfish prices are finally dropping, but farmers and fishers are still struggling
Last year’s devastating drought in Louisiana killed off large crops of crawfish, leading to a tough season for farmers, fishers and seafood lovers.
Lawmakers consider medical cannabis revamp
It’s been three years since Alabama lawmakers passed legislation establishing a system to govern medical cannabis in the state, yet not one prescription for the drug has been filled. The rollout has been delayed by lawsuits and conflict over the licensing process.
